Sign Up
OverviewAPI
The global oncology drugs market is poised to expand significantly, with a projected CAGR of 11.53%, reaching $474.06 billion by 2030. Key drivers are the increasing cancer cases, treatment advancements, and rising tobacco use. Major pharmaceutical companies are focusing on R&D, leading to notable M&A activities.

Ask a question